Page last updated: 2024-08-24
celgosivir and HIV
celgosivir has been researched along with HIV in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kang, MS | 1 |
| Torres, G | 1 |
Trials
1 trial(s) available for celgosivir and HIV
| Article | Year |
|---|---|
BUCAST: another new antiviral.
Topics: Animals; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Glycoside Hydrolases; HIV; Humans; Indolizines; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1995 |
Other Studies
1 other study(ies) available for celgosivir and HIV
| Article | Year |
|---|---|
Uptake and metabolism of BuCast: a glycoprotein processing inhibitor and a potential anti-HIV drug.
Topics: Animals; Antiviral Agents; Brain; Cells, Cultured; Dose-Response Relationship, Drug; Female; Glycoproteins; HIV; Humans; Indolizines; Liver; Mice; Mice, Inbred C57BL; Protein Processing, Post-Translational; Spleen; Thymus Gland; Tissue Distribution | 1996 |